P14.30 Treatment outcomes of newly-diagnosed glioblastoma multiforme (GBM) by O6-methylguanine DNA methyltransferase promoter (MGMT) status: a multi-country study

Yazar: Fu, A Z, Hall, J P, Bailey, A, Kemp, J, Thompson, G J, Lee, C
Yayımlandı Neuro Oncol (2019)

P14.36 Treatment patterns by O6-methylguanine DNA methyltransferase promoter (MGMT) status in newly-diagnosed glioblastoma multiforme (GBM): a multi-country chart review study

Yazar: Fu, A Z, Thompson, G J, Hall, J P, Bailey, A, Kemp, J, Lee, C
Yayımlandı Neuro Oncol (2019)

Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study

Yazar: Tsai, H.-T., Isaacs, C., Fu, A. Z., Warren, J. L., Freedman, A. N., Barac, A., Huang, C.-Y., Potosky, A. L.
Baskı/Yayın Bilgisi 2014

Using an Automated Recruitment Process to Generate an Unbiased Study Sample of Multiple Sclerosis Patients

Yazar: Miller, Deborah M., Fox, R., Atreja, A., Moore, S., Lee, J.-C., Fu, A.Z., Jain, A., Saupe, W., Chakraborty, S., Stadtler, M., Rudick, R.A.
Baskı/Yayın Bilgisi 2010

Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study

Yazar: Tsai, H.-T., Marshall, J. L., Weiss, S. R., Huang, C.-Y., Warren, J. L., Freedman, A. N., Fu, A. Z., Sansbury, L. B., Potosky, A. L.
Baskı/Yayın Bilgisi 2013